InSilico Medicine Cayman TopCo (HKG:3696)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
60.80
-1.60 (-2.56%)
At close: Apr 17, 2026

HKG:3696 Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Net Income
-17.1-211.64-221.83
Depreciation & Amortization
6.054.481.78
Loss (Gain) From Sale of Assets
-0.012.19
Loss (Gain) From Sale of Investments
-0.56-0.451.04
Stock-Based Compensation
3.2610.7912.92
Provision & Write-off of Bad Debts
-0.01-0.160.23
Other Operating Activities
-15.91122.23138.53
Change in Accounts Receivable
2.862.11-5.95
Change in Accounts Payable
0.299.1412.69
Change in Unearned Revenue
-35.5637.435.03
Change in Other Net Operating Assets
-0.73-3.525.84
Operating Cash Flow
-57.4-29.58-47.52
Capital Expenditures
-0.84-2.56-10.98
Sale of Property, Plant & Equipment
-0.01-
Divestitures
---2.22
Sale (Purchase) of Intangibles
-0.08-0.41-0.24
Other Investing Activities
8.353.66-0.15
Investing Cash Flow
7.420.69-13.58
Long-Term Debt Repaid
-1.56-1.4-0.97
Net Debt Issued (Repaid)
-1.56-1.4-0.97
Issuance of Common Stock
0.410.010.21
Other Financing Activities
-0.38-0.79-1.83
Financing Cash Flow
-1.54-2.18107.15
Foreign Exchange Rate Adjustments
0.280.370.29
Net Cash Flow
-51.24-30.746.34
Free Cash Flow
-58.25-32.14-58.5
Free Cash Flow Margin
-67.86%-62.79%-194.03%
Free Cash Flow Per Share
-0.81-0.48-0.87
Cash Interest Paid
0.090.090.1
Levered Free Cash Flow
-56.4128.96-
Unlevered Free Cash Flow
-56.34129.02-
Change in Working Capital
-33.1445.1617.62
Source: S&P Global Market Intelligence. Standard template. Financial Sources.